Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/20827276 offsetBegin: 1877 offsetEnd: 2026 A: polyadenylation signal accompanied by a poly(T) sequence and a target site duplication. The insertion site matched the consensus recognition sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11421362 offsetBegin: 3672 offsetEnd: 3813 A: site consensus sequence that is critical for splicing enhancer activity. Mutations within this pseudo-5' splice site sequence have a dramatic
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11024279 offsetBegin: 2835 offsetEnd: 2983 A: a non-standard polyadenylation consensus sequence while the 3kb transcript contains a standard consensus sequence but within the open reading frame.
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/12556531 offsetBegin: 2077 offsetEnd: 2223 A: extra polyadenylation site at 19 nt. The 3'-untranslated region sequence is AU-rich and has putative consensus sequences for RNA-binding proteins.
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/20827276 offsetBegin: 2026 offsetEnd: 2165 A: sequence and a target site duplication. The insertion site matched the consensus recognition sequence for the L1 endonuclease, indicating a
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11024279 offsetBegin: 2674 offsetEnd: 2835 A: UTR. Furthermore, the 4.2kb transcript contains a non-standard polyadenylation consensus sequence while the 3kb transcript contains a standard consensus sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/18514032 offsetBegin: 2141 offsetEnd: 2291 A: an AU-rich domain corresponding to the consensus UA(A/U)UU polyadenylation signal or variants, the cleavage and polyadenylation site that is generally
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/18514032 offsetBegin: 2291 offsetEnd: 2435 A: consensus UA(A/U)UU polyadenylation signal or variants, the cleavage and polyadenylation site that is generally denoted by U residue and flanked
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/12446815 offsetBegin: 4398 offsetEnd: 4546 A: contained both the consensus stem-loop sequence and the polyadenylation signals but lacked the consensus histone downstream element that is involved
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/20827276 offsetBegin: 2165 offsetEnd: 2327 A: The insertion site matched the consensus recognition sequence for the L1 endonuclease, indicating a retrotransposon-mediated event, although the inserted sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9869401 offsetBegin: 1551 offsetEnd: 1690 A: and 3'-flanking regions revealed a consensus TATA-box sequence located 28 bp upstream of the transcription initiation site as determined by
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11421362 offsetBegin: 3398 offsetEnd: 3534 A: specifically to SEalpha2. SEalpha2 also includes an element resembling a 5' splice site consensus sequence that is critical for splicing
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11421362 offsetBegin: 3534 offsetEnd: 3672 A: an element resembling a 5' splice site consensus sequence that is critical for splicing enhancer activity. Mutations within this pseudo-5'
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9710581 offsetBegin: 2582 offsetEnd: 2701 A: exon 4, via factors binding to an intronic enhancer element that contains both 3' and 5' splice site consensus sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9710581 offsetBegin: 2833 offsetEnd: 2960 A: both 3' and 5' splice site consensus sequence elements. In cell types that preferentially exclude exon 4, addition of wild-type
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9651483 offsetBegin: 3382 offsetEnd: 3536 A: untranslated region contains consensus polyadenylation signal (AATAAA). We also isolated an intronless gene with 93% nucleotide sequence similarity to the
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/15248021 offsetBegin: 1101 offsetEnd: 1251 A: poly(A) tail attachment sites. However, polyadenylation consensus sequence AAUAAA was not seen at the 3'-untranslated sequence. PSG076 contained a 299
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/12556531 offsetBegin: 1949 offsetEnd: 2077 A: with 225 microM emetine exhibited an extra polyadenylation site at 19 nt. The 3'-untranslated region sequence is AU-rich and has
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10438805 offsetBegin: 4200 offsetEnd: 4330 A: The late polyadenylation signal was found to contain a single high-affinity site for CstF, as well as one consensus hexanucleotide
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9837805 offsetBegin: 3940 offsetEnd: 4102 A: the consensus protease cleavage site. Genomic and cDNA sequence analysis has identified promoters, cap sites, intron-exon boundaries, polyadenylation signals, and
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9869401 offsetBegin: 1277 offsetEnd: 1420 A: bp, all have conserved junction sequences (GT..AG). Sequence analysis of the 5'- and 3'-flanking regions revealed a consensus TATA-box sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9869401 offsetBegin: 1968 offsetEnd: 2107 A: determined by primer extension analysis, and a putative polyadenylation signal observed 29 bp upstream of the polyadenylation site based on
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9869401 offsetBegin: 2107 offsetEnd: 2247 A: a putative polyadenylation signal observed 29 bp upstream of the polyadenylation site based on cDNA sequence. Genomic Southern blot analysis
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/12552250 offsetBegin: 2604 offsetEnd: 2728 A: a prominent binding site, 130 base pairs upstream of the EBER1 gene, contains two E-boxes providing a consensus sequence for
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9705920 offsetBegin: 2745 offsetEnd: 2876 A: tract for directing polyadenylation and a gene end sequence that differs from the consensus sequence. We have tested the hypothesis
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/21558555 offsetBegin: 1814 offsetEnd: 1960 A: prominent kinase with a consensus site for phosphorylation that overlapped with caspase recognition motifs. We then evaluated potential targets of
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10501966 offsetBegin: 3676 offsetEnd: 3827 A: for ubiquitin thioester formation and the active site consensus sequence that defines the ubiquitin-conjugating enzyme class. These observations are of
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10501966 offsetBegin: 3827 offsetEnd: 3979 A: active site consensus sequence that defines the ubiquitin-conjugating enzyme class. These observations are of particular relevance for analysis of UbcM4
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/23151878 offsetBegin: 2931 offsetEnd: 3104 A: These experiments identified cleavage and polyadenylation specificity factor 1 (CPSF1) among protein-binding candidates. A consensus polyadenylation signal AAUAAA is present
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10832023 offsetBegin: 939 offsetEnd: 1089 A: 1alpha-hydroxylase and human vitamin D(3) 25-hydroxylase genes. A polyadenylation signal AUUAAA that differs from the consensus sequence at the second
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10832023 offsetBegin: 1089 offsetEnd: 1222 A: genes. A polyadenylation signal AUUAAA that differs from the consensus sequence at the second residue was identified 16 bp downstream
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9710581 offsetBegin: 2701 offsetEnd: 2833 A: an intronic enhancer element that contains both 3' and 5' splice site consensus sequence elements. In cell types that preferentially
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/23308270 offsetBegin: 1386 offsetEnd: 1523 A: as a direct and prominent target of Gfi1b. Examination of the meis1 promoter sequence revealed multiple Gfi1/1b consensus binding motifs.
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/20827276 offsetBegin: 1718 offsetEnd: 1877 A: certain characteristics of retrotransposons: an antisense polyadenylation signal accompanied by a poly(T) sequence and a target site duplication. The insertion
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9753737 offsetBegin: 3370 offsetEnd: 3504 A: identify a consensus sequence but did reveal weak putative 3'-end formation signals in all of the transcripts. Similarly, no consensus
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/15248021 offsetBegin: 815 offsetEnd: 965 A: with different length were produced from the single gene based on different poly(A) tail attachment sites. However, polyadenylation consensus sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/15248021 offsetBegin: 965 offsetEnd: 1101 A: the single gene based on different poly(A) tail attachment sites. However, polyadenylation consensus sequence AAUAAA was not seen at the
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10448076 offsetBegin: 2703 offsetEnd: 2863 A: polyadenylation site was identified in the 3' flanking region. SP-HSP70 protein sequence resembles the cytosolic/nuclear HSP70 cluster. RT-PCR studies confirmed
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9858533 offsetBegin: 3463 offsetEnd: 3595 A: in vivo and exon polyadenylation in vitro. An additional PTB binding site was identified close to the AAUAAA hexanucleotide sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/22162666 offsetBegin: 967 offsetEnd: 1089 A: the highest for the consensus sequence and the lowest for splice sites differing most from the consensus sequence and used
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/12446815 offsetBegin: 4262 offsetEnd: 4398 A: The 3'UTRs of the histone genes contained both the consensus stem-loop sequence and the polyadenylation signals but lacked the consensus
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10974564 offsetBegin: 634 offsetEnd: 749 A: site consensus is TATAT, with a 4bp target site duplication TATA. The LTRs are short (142bp) and contain a TATA-box
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/10974564 offsetBegin: 1470 offsetEnd: 1641 A: polyprotein coding sequence contains scattered stop codons and deletions/insertions at non-homologous positions. The consensus sequence among the three full-length copies,
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/21558555 offsetBegin: 1547 offsetEnd: 1676 A: caspases and kinases. We identified the protein kinase CK2 as the most prominent kinase with a consensus site for phosphorylation
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/21558555 offsetBegin: 1676 offsetEnd: 1814 A: protein kinase CK2 as the most prominent kinase with a consensus site for phosphorylation that overlapped with caspase recognition motifs.
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/8442668 offsetBegin: 2357 offsetEnd: 2499 A: acetylator phenotype and NAT2 genotype. A prominent alteration in one of the variants was obliteration of the consensus polyadenylation signal
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/17020919 offsetBegin: 2611 offsetEnd: 2737 A: A sequence overlapping this sense start site contains a good match to an initiator consensus for the transcription start sites
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11152070 offsetBegin: 833 offsetEnd: 969 A: untranslated regions of the actA gene contain a consensus TATA box, a CCAAT motif, pyrimidine stretches and the polyadenylation sequence
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/11152070 offsetBegin: 969 offsetEnd: 1107 A: contain a consensus TATA box, a CCAAT motif, pyrimidine stretches and the polyadenylation sequence AATAA. The predicted protein (375 amino
Q:What is the most prominent sequence consensus for the polyadenylation site? Document:http://www.ncbi.nlm.nih.gov/pubmed/9266998 offsetBegin: 3098 offsetEnd: 3237 A: prominent polyadenylation consensus motifs in the region of UL54. All transcripts were identified early in the infectious cycle, except for
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 1398 offsetEnd: 1537 A: associated with ophthalmopathy. The thyrotropin receptor (TSHR) is expressed at low levels in several connective tissue depots and by their
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/7794253 offsetBegin: 0 offsetEnd: 154 A: There is increasing evidence that the membrane-bound thyrotropin receptor (TSHR) may be mediating clinically important direct effects of thyrotropin (TSH)
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 1120 offsetEnd: 1258 A: in Graves' disease might play an integral role in the tissue remodeling associated with ophthalmopathy. The thyrotropin receptor (TSHR) is
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 1258 offsetEnd: 1398 A: integral role in the tissue remodeling associated with ophthalmopathy. The thyrotropin receptor (TSHR) is expressed at low levels in several
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/7794253 offsetBegin: 154 offsetEnd: 305 A: membrane-bound thyrotropin receptor (TSHR) may be mediating clinically important direct effects of thyrotropin (TSH) and of TSHR antibodies (TSHRab) in
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 728 offsetEnd: 849 A: is unknown but current evidence favors an immune reaction against a thyroid and orbital tissue shared antigen such as the
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 849 offsetEnd: 966 A: an immune reaction against a thyroid and orbital tissue shared antigen such as the novel protein G2s, which is highly
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 449 offsetEnd: 610 A: Several authors have presented data suggesting that extrathyroidal tissues, e.g. extraocular muscle (EOM), may contain a functional thyrotropin receptor (TSH-R).
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 610 offsetEnd: 762 A: that extrathyroidal tissues, e.g. extraocular muscle (EOM), may contain a functional thyrotropin receptor (TSH-R). We have applied Northern blotting and
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 762 offsetEnd: 896 A: (EOM), may contain a functional thyrotropin receptor (TSH-R). We have applied Northern blotting and PCR amplification in an attempt to
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/18400223 offsetBegin: 2596 offsetEnd: 2752 A: in virtually all extra-thyroidal tissues expressing TSHRa, whereas TSHRc shows a more restricted tissue distribution. Whether these receptor transcripts are
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 0 offsetEnd: 155 A: Thyroid associated ophthalmopathy (TAO) is an autoimmune disease involving the extra ocular muscles and surrounding orbital connective and adipose tissues.
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 143 offsetEnd: 297 A: thyroid associated ophthalmopathy (TAO) and a possible link with the thyroid continues. Several authors have presented data suggesting that extrathyroidal
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12045258 offsetBegin: 2659 offsetEnd: 2818 A: radioligand receptor assay. The heterodimer also stimulated cAMP production and thymidine incorporation by cultured thyroid cells and increased serum thyroxine
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/19553036 offsetBegin: 3597 offsetEnd: 3746 A: lymphatic vessels and in corpora haemorragica and albicantia. Bovine thyroid tissue showed immunostaining to both the antibodies employed. These data
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/19553036 offsetBegin: 3746 offsetEnd: 3882 A: and albicantia. Bovine thyroid tissue showed immunostaining to both the antibodies employed. These data suggest that the luteal cells of
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/18400223 offsetBegin: 0 offsetEnd: 139 A: We previously described the cloning of the full-length chicken thyrotropin receptor (TSHRa) and two splice variants, lacking exon 3 (TSHRb)
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/18400223 offsetBegin: 2752 offsetEnd: 2899 A: TSHRa, whereas TSHRc shows a more restricted tissue distribution. Whether these receptor transcripts are translated to functional proteins needs to
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/18400223 offsetBegin: 2899 offsetEnd: 3041 A: restricted tissue distribution. Whether these receptor transcripts are translated to functional proteins needs to be verified, but if so, they
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 588 offsetEnd: 728 A: link between ophthalmopathy and thyroid autoimmunity is unknown but current evidence favors an immune reaction against a thyroid and orbital
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 0 offsetEnd: 143 A: The search for autoantigenic targets in thyroid associated ophthalmopathy (TAO) and a possible link with the thyroid continues. Several authors
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/18400223 offsetBegin: 139 offsetEnd: 261 A: the full-length chicken thyrotropin receptor (TSHRa) and two splice variants, lacking exon 3 (TSHRb) or both exons 2 and 3
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/20464711 offsetBegin: 0 offsetEnd: 128 A: Thyroid associated ophthalmopathy, or thyroid eye disease (TED), is a complex inflammatory disorder of the eye that, as its name
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/22125104 offsetBegin: 0 offsetEnd: 128 A: Thyroid associated ophthalmopathy, or thyroid eye disease (TED), is a complex inflammatory disorder of the eye that, as its name
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/9167947 offsetBegin: 1910 offsetEnd: 2024 A: signs of immunity, a pathology similar to toxic nodule, the need for a total destruction of thyroid tissue to cure
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/9167947 offsetBegin: 2136 offsetEnd: 2248 A: a total destruction of thyroid tissue to cure the patients. The total analogy with toxic nodule leads us to name
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/19553036 offsetBegin: 0 offsetEnd: 132 A: The receptor of the Thyroid Stimulating Hormone (TSHr) and thyroglobin (TGB), are two proteic factors necessary for the synthesis of
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/19553036 offsetBegin: 3452 offsetEnd: 3597 A: detected in stromal cells, blood and lymphatic vessels and in corpora haemorragica and albicantia. Bovine thyroid tissue showed immunostaining to
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/9167947 offsetBegin: 2024 offsetEnd: 2136 A: to toxic nodule, the need for a total destruction of thyroid tissue to cure the patients. The total analogy with
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 1192 offsetEnd: 1313 A: is highly expressed in both eye muscles and thyroid, or the TSH receptor (TSHR). Earlier, we showed that serum antibodies
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 1313 offsetEnd: 1437 A: muscles and thyroid, or the TSH receptor (TSHR). Earlier, we showed that serum antibodies against G2s were closely linked to
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 1437 offsetEnd: 1586 A: receptor (TSHR). Earlier, we showed that serum antibodies against G2s were closely linked to ophthalmopathy. Although lymphocytic infiltration of the
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 3996 offsetEnd: 4142 A: seven patients with Hashimoto's thyroiditis, suggesting that immune reactivity against G2s could be a marker of this progressive thyroid disorder.
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 4142 offsetEnd: 4277 A: that immune reactivity against G2s could be a marker of this progressive thyroid disorder. There was no significant correlation between
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 4277 offsetEnd: 4400 A: be a marker of this progressive thyroid disorder. There was no significant correlation between T cell reactivity to G2s and
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12515285 offsetBegin: 4400 offsetEnd: 4534 A: thyroid disorder. There was no significant correlation between T cell reactivity to G2s and serum antibodies against the same protein,
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/3360902 offsetBegin: 437 offsetEnd: 590 A: variable degrees of reactivity with eye muscle, orbital connective tissue, thyroid, and extra-thyroid tissue preparations when tested in an enzyme-linked
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/3360902 offsetBegin: 590 offsetEnd: 745 A: muscle, orbital connective tissue, thyroid, and extra-thyroid tissue preparations when tested in an enzyme-linked immunosorbent assay (ELISA). Eight of the
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/3360902 offsetBegin: 3788 offsetEnd: 3941 A: thyroid disorders, and 20 normal subjects for reactivity with an affinity-purified nonprotein orbital antigen. The levels of serum autoantibodies against
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 1537 offsetEnd: 1668 A: (TSHR) is expressed at low levels in several connective tissue depots and by their derivative fibroblasts, including those from the
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 1668 offsetEnd: 1811 A: in several connective tissue depots and by their derivative fibroblasts, including those from the orbit. Little direct evidence currently links
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 2119 offsetEnd: 2281 A: currently links extra-thyroidal TSHR expression with Graves' disease. Very recent observations now implicate the insulin-like growth factor-1 receptor (IGF-1R) as
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/14669949 offsetBegin: 2281 offsetEnd: 2444 A: Graves' disease. Very recent observations now implicate the insulin-like growth factor-1 receptor (IGF-1R) as a fibroblast activating antigen. When immunoglobulins
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 297 offsetEnd: 449 A: possible link with the thyroid continues. Several authors have presented data suggesting that extrathyroidal tissues, e.g. extraocular muscle (EOM), may
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/8320423 offsetBegin: 2251 offsetEnd: 2372 A: in the thyroid. PCR amplification was performed on thyroid and EOM cDNAs using pairs of primers designed to amplify exons
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/12045258 offsetBegin: 2513 offsetEnd: 2659 A: affinity to TSH receptors in a radioligand receptor assay. The heterodimer also stimulated cAMP production and thymidine incorporation by cultured
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/18400223 offsetBegin: 2464 offsetEnd: 2596 A: and -f mRNA was also present in virtually all extra-thyroidal tissues expressing TSHRa, whereas TSHRc shows a more restricted tissue
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/20464711 offsetBegin: 384 offsetEnd: 524 A: its name implies, is usually associated with thyroid disease. Clinical observation supports the existence of three main TED subtypes, namely
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/20464711 offsetBegin: 1740 offsetEnd: 1903 A: a specific orbital or thyroid-and-orbital shared antigen(s). One well-studied candidate in this immune reaction is the thyroid-stimulating hormone receptor (TSHR),
Q:Which extra thyroid tissues have thyrotropin (TSH) receptors? Document:http://www.ncbi.nlm.nih.gov/pubmed/20464711 offsetBegin: 2197 offsetEnd: 2348 A: receptor (TSHR), which is also expressed in the orbital fibroblast and preadipocyte. Most patients with ophthalmopathy have associated Graves' disease,
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/2190527 offsetBegin: 3906 offsetEnd: 4018 A: at the same time. Examples are type I and type II cancer family syndrome and multiple endocrine neoplasia type 1
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/2190527 offsetBegin: 4018 offsetEnd: 4134 A: type I and type II cancer family syndrome and multiple endocrine neoplasia type 1 2a, and 2b. The secondly diagnosed
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/12203793 offsetBegin: 0 offsetEnd: 146 A: Multiple endocrine neoplasia type 1 is an autosomal dominant cancer predisposition syndrome caused by mutations in the tumor-suppressor gene MEN1.
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 2959 offsetEnd: 3124 A: organ hyperplasia, which determines hyperfunction, or endocrine organs neoplasia. For patients with multiple endocrine neoplasia type 1 syndrome, endocrine neoplasia
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10849016 offsetBegin: 0 offsetEnd: 144 A: BACKGROUND: Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal, dominantly inherited cancer syndrome, with tumours in various endocrine
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 0 offsetEnd: 141 A: Multiple endocrine neoplasia (MEN) type 1 syndrome or Wermer syndrome is a classical malignant neoplasia syndrome, inherited in the autosomal
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 3124 offsetEnd: 3276 A: endocrine organs neoplasia. For patients with multiple endocrine neoplasia type 1 syndrome, endocrine neoplasia develops earlier than in sporadic cases;
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10612420 offsetBegin: 127 offsetEnd: 263 A: a tumor suppressor gene MEN1, mutations of which are responsible for multiple endocrine neoplasia type 1, an autosomal dominant familial
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10989951 offsetBegin: 135 offsetEnd: 263 A: mutations as the molecular cause of familial multiple endocrine neoplasia type 1 syndrome (MEN1) has had a significant impact on
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10989951 offsetBegin: 263 offsetEnd: 395 A: familial multiple endocrine neoplasia type 1 syndrome (MEN1) has had a significant impact on clinical patient care. In the following
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/2880443 offsetBegin: 0 offsetEnd: 146 A: Hyperparathyroidism (HPT) in the syndrome of multiple endocrine neoplasia type 1 (MEN-1) exhibits a different picture regarding its propensity for
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/9681845 offsetBegin: 0 offsetEnd: 147 A: Multiple endocrine neoplasia type 1 (MEN-1) is a well characterized hereditary syndrome with the occurrence of primary hyperparathyroidism (HPT) in
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15077908 offsetBegin: 3640 offsetEnd: 3777 A: to high grade malignant for poorly differentiated carcinomas. The Multiple Endocrine Neoplasia type 1 syndrome (MEN1) gene is involved in
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10458257 offsetBegin: 644 offsetEnd: 785 A: mutations in RET cause multiple endocrine neoplasia type 2 (MEN 2), an inherited cancer syndrome characterized by medullary thyroid carcinoma
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/2190527 offsetBegin: 4134 offsetEnd: 4261 A: family syndrome and multiple endocrine neoplasia type 1 2a, and 2b. The secondly diagnosed tumours are not caused by metastatic
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/14648742 offsetBegin: 125 offsetEnd: 249 A: sporadic endocrine tumour may be different from those that present as part of the multiple endocrine neoplasia type 1 (MEN1)
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 6289 offsetEnd: 6450 A: review is to introduce medical-practitioners to the newest theories of type 1 multiple endocrine neoplasia syndrome pathogenesis, clinical peculiarities, methods
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/6129792 offsetBegin: 0 offsetEnd: 152 A: Multiple endocrine neoplasia syndrome IIB is an inherited autosomal dominant disorder with variable penetrance. Multiple organ systems are involved with
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10989951 offsetBegin: 0 offsetEnd: 135 A: The recent identification of MEN1 gene mutations as the molecular cause of familial multiple endocrine neoplasia type 1 syndrome (MEN1)
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/14648742 offsetBegin: 382 offsetEnd: 536 A: of the multiple endocrine neoplasia type 1 (MEN1) syndrome. As primary hyperparathyroidism (pHPT) and pancreaticoduodenal endocrine tumours (PETs) are the
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15077908 offsetBegin: 3777 offsetEnd: 3910 A: differentiated carcinomas. The Multiple Endocrine Neoplasia type 1 syndrome (MEN1) gene is involved in the genesis of a proportion of
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 3276 offsetEnd: 3431 A: multiple endocrine neoplasia type 1 syndrome, endocrine neoplasia develops earlier than in sporadic cases; multifocality is typical for them. Multifocality
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/19654304 offsetBegin: 0 offsetEnd: 128 A: The phenotype of the multiple endocrine neoplasia type 1 (MEN1) syndrome cannot be explained solely by the expression pattern of
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 2799 offsetEnd: 2959 A: all the patients diagnosed with endocrine organ hyperplasia, which determines hyperfunction, or endocrine organs neoplasia. For patients with multiple endocrine
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/16898326 offsetBegin: 401 offsetEnd: 539 A: associated as part of a tumour syndrome including Von Hippel Lindau (VHL), Multiple Endocrine Neoplasia (MEN) 2 and Neurofibromatosis Type
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/16898326 offsetBegin: 539 offsetEnd: 684 A: syndrome including Von Hippel Lindau (VHL), Multiple Endocrine Neoplasia (MEN) 2 and Neurofibromatosis Type 1. VHL is associated with multi-organ
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10612420 offsetBegin: 263 offsetEnd: 398 A: of which are responsible for multiple endocrine neoplasia type 1, an autosomal dominant familial cancer syndrome. We isolated rat menin
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/672141 offsetBegin: 0 offsetEnd: 152 A: As pheochromocytoma sometimes is accompanied by medullary thyroid carcinoma (in the sense of multiple endocrine adonomatosis type II = Sipple-Syndrome),
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/2880443 offsetBegin: 146 offsetEnd: 294 A: multiple endocrine neoplasia type 1 (MEN-1) exhibits a different picture regarding its propensity for recurrence compared with sporadic primary HPT.
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/20951316 offsetBegin: 135 offsetEnd: 275 A: and clinical genetics of solid tumors associated with the various multiple endocrine neoplasias (MEN) syndromes. MEN type 1 (MEN1) describes
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 4301 offsetEnd: 4453 A: which is also important in determining the inheritors of mutations, potential patients. After genetically diagnosing multiple endocrine neoplasia type 1
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 4453 offsetEnd: 4596 A: the inheritors of mutations, potential patients. After genetically diagnosing multiple endocrine neoplasia type 1 syndrome, it is not enough to
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10458257 offsetBegin: 785 offsetEnd: 945 A: neoplasia type 2 (MEN 2), an inherited cancer syndrome characterized by medullary thyroid carcinoma (MTC), pheochromocytoma (PC), and hyperparathyroidism (HPT).
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/17961654 offsetBegin: 254 offsetEnd: 388 A: isolated cases, sometimes due to a predisposing syndrome. In multiple endocrine neoplasia type 1, they often associate with a mutation
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/17961654 offsetBegin: 388 offsetEnd: 526 A: predisposing syndrome. In multiple endocrine neoplasia type 1, they often associate with a mutation of the menin gene, a tumor-suppressing
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/2190527 offsetBegin: 3791 offsetEnd: 3906 A: syndromes different organs may be affected at the same time. Examples are type I and type II cancer family syndrome
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/19734639 offsetBegin: 2978 offsetEnd: 3114 A: and Ki67 below 1%. Considering the patient's clinical history, an inherited cause was postulated and multiple endocrine neoplasia type 1
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/19734639 offsetBegin: 3114 offsetEnd: 3254 A: patient's clinical history, an inherited cause was postulated and multiple endocrine neoplasia type 1 was first investigated, but the result
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/19734639 offsetBegin: 4039 offsetEnd: 4189 A: distant tumor recurrences are usually reported in radically operated on von Hippel-Lindau pancreatic neuroendocrine tumor patients after a median time
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/14648742 offsetBegin: 249 offsetEnd: 382 A: from those that present as part of the multiple endocrine neoplasia type 1 (MEN1) syndrome. As primary hyperparathyroidism (pHPT) and
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/8551667 offsetBegin: 898 offsetEnd: 1048 A: Production of growth hormone-releasing hormone (GHRH) by an ectopic tumor was suspected and, after additional investigations, a large pancreatic tumor
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/22001208 offsetBegin: 532 offsetEnd: 666 A: endocrine neoplasia type 1) tumor suppressor gene, represents a common feature of several fatty liver mouse models. The liver specific
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/20951316 offsetBegin: 275 offsetEnd: 424 A: associated with the various multiple endocrine neoplasias (MEN) syndromes. MEN type 1 (MEN1) describes the association of pituitary, parathyroid, and
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 2643 offsetEnd: 2799 A: syndrome developing should be estimated for all the patients diagnosed with endocrine organ hyperplasia, which determines hyperfunction, or endocrine organs
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/15170420 offsetBegin: 4596 offsetEnd: 4727 A: After genetically diagnosing multiple endocrine neoplasia type 1 syndrome, it is not enough to analyze and look after patients with
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10458257 offsetBegin: 530 offsetEnd: 644 A: in every cell of the body) mutations in RET cause multiple endocrine neoplasia type 2 (MEN 2), an inherited cancer
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/10612420 offsetBegin: 0 offsetEnd: 127 A: Menin is a protein product of a tumor suppressor gene MEN1, mutations of which are responsible for multiple endocrine neoplasia
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/8551667 offsetBegin: 0 offsetEnd: 146 A: A 51-year-old Caucasian man with multiple endocrine neoplasia (MEN) type I syndrome presented with clinical features of acromegaly. Exploration of
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/8551667 offsetBegin: 1048 offsetEnd: 1177 A: by an ectopic tumor was suspected and, after additional investigations, a large pancreatic tumor was detected and removed. As the
Q:Tumors of which three organs are classically associated with the multiple endocrine neoplasia type 1 syndrome? Document:http://www.ncbi.nlm.nih.gov/pubmed/22001208 offsetBegin: 403 offsetEnd: 532 A: the product of the MEN1 (multiple endocrine neoplasia type 1) tumor suppressor gene, represents a common feature of several fatty
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 1105 offsetEnd: 1260 A: presentation, and treatment options for juvenile myasthenia gravis. RECENT FINDINGS: Randomized clinical studies of myasthenia gravis have been carried out
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22337799 offsetBegin: 619 offsetEnd: 792 A: acetylcholinesterase inhibitors (AChEIs). AChEIs are used for the treatment of Alzheimer's Disease and Myasthenia Gravis. In the open-tubular capillary electrochromatography
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22634638 offsetBegin: 4589 offsetEnd: 4722 A: can be considered for symptomatic treatment of myasthenia gravis and other congenital myasthenic syndromes as an inhibitor of AChE in
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21236521 offsetBegin: 0 offsetEnd: 151 A: Inhibitors of acetylcholinesterase are compounds widely used in the treatment of various diseases, such as Alzheimer's disease, glaucoma and Myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21440438 offsetBegin: 3198 offsetEnd: 3343 A: suspected to have CMS, especially if treatment response is incomplete, or no CMS gene mutation is identified. Treatment with acetylcholinesterase
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21440438 offsetBegin: 3343 offsetEnd: 3493 A: treatment response is incomplete, or no CMS gene mutation is identified. Treatment with acetylcholinesterase inhibitors may benefit some CNM patients.
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 4002 offsetEnd: 4179 A: myasthenia gravis patients diagnosed by an internationally accepted definition.Types of interventions: treatment with any form of acetylcholinesterase inhibitor.Types of outcome
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 8445 offsetEnd: 8606 A: trial has been conducted on the use of acetylcholinesterase inhibitors in myasthenia gravis. Response to acetylcholinesterase inhibitors in observational studies
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 8606 offsetEnd: 8765 A: use of acetylcholinesterase inhibitors in myasthenia gravis. Response to acetylcholinesterase inhibitors in observational studies is so clear that a randomised
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22337799 offsetBegin: 458 offsetEnd: 619 A: the separation of the pharmaceutical substances acetylcholinesterase inhibitors (AChEIs). AChEIs are used for the treatment of Alzheimer's Disease and Myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22091897 offsetBegin: 2510 offsetEnd: 2671 A: keywords were used: myasthenia gravis AND neuromuscular blocking agents, myasthenia gravis AND sevoflurane, myasthenia gravis AND epidural, myasthenia gravis AND
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22091897 offsetBegin: 2350 offsetEnd: 2510 A: references of the articles. The following keywords were used: myasthenia gravis AND neuromuscular blocking agents, myasthenia gravis AND sevoflurane, myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22091897 offsetBegin: 2671 offsetEnd: 2844 A: neuromuscular blocking agents, myasthenia gravis AND sevoflurane, myasthenia gravis AND epidural, myasthenia gravis AND neuromuscular blockade reversal and myasthenia gravis
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22091897 offsetBegin: 2844 offsetEnd: 3011 A: sevoflurane, myasthenia gravis AND epidural, myasthenia gravis AND neuromuscular blockade reversal and myasthenia gravis AND pyridostigmine. The articles included were
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22849994 offsetBegin: 0 offsetEnd: 119 A: We report a 33-year-old woman with myasthenia gravis (MG) who developed optic neuritis after the treatment of MG for 22
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 1963 offsetEnd: 2114 A: prospective randomized controlled data to evaluate treatment outcomes and efficacy. A recent retrospective series suggests that, as in adult myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21614992 offsetBegin: 1360 offsetEnd: 1475 A: inhibitor drugs are used in treatment of CMS. A seven-month old male patient was brought to our department with the
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 2680 offsetEnd: 2843 A: quasi-randomised controlled trials regarding usage of acetylcholinesterase inhibitors in myasthenia gravis. Two authors scanned the articles for any study eligible
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 7160 offsetEnd: 7314 A: trials. MAIN RESULTS: We did not find any large randomised or quasi-randomised trials of acetylcholinesterase inhibitors in generalised myasthenia gravis.
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/20842584 offsetBegin: 0 offsetEnd: 160 A: OPINION STATEMENT: Treatment of patients with acquired (autoimmune) myasthenia gravis should rely on evidence-based therapeutic choices, taking into account the
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21969350 offsetBegin: 609 offsetEnd: 758 A: concordance occurs in approximately one third of such identical twin pairs; and treatment for myasthenia gravis, when described,is usually concordant
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21969350 offsetBegin: 901 offsetEnd: 1047 A: treatment for myasthenia gravis, when described,is usually concordant in identical twin pairs (2). OBJECTIVE: To report an 11-year clinical course
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/23338057 offsetBegin: 1828 offsetEnd: 1968 A: that the muscle weakness seen in these animals can be significantly alleviated by treatment with an acetylcholinesterase inhibitor. Based on
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/23338057 offsetBegin: 2964 offsetEnd: 3133 A: of the individuals. All five patients showed improved muscle strength and motor function, and/or reduced fatigability following acetylcholinesterase inhibitor treatment.
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/23338057 offsetBegin: 3133 offsetEnd: 3308 A: showed improved muscle strength and motor function, and/or reduced fatigability following acetylcholinesterase inhibitor treatment. Together, our results suggest that deficits
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/23338057 offsetBegin: 3308 offsetEnd: 3480 A: function, and/or reduced fatigability following acetylcholinesterase inhibitor treatment. Together, our results suggest that deficits at the neuromuscular junction may play
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22634638 offsetBegin: 4283 offsetEnd: 4439 A: respiratory diaphragm muscles and external intercostal muscles. These observations show that C-547 can be considered for symptomatic treatment of myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22634638 offsetBegin: 4439 offsetEnd: 4589 A: muscles. These observations show that C-547 can be considered for symptomatic treatment of myasthenia gravis and other congenital myasthenic syndromes
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21440438 offsetBegin: 1608 offsetEnd: 1765 A: XLMTM case) showed improved strength with acetylcholinesterase inhibitor treatment. We also studied neuromuscular junction structure and function in the MTM1
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21440438 offsetBegin: 1765 offsetEnd: 1930 A: acetylcholinesterase inhibitor treatment. We also studied neuromuscular junction structure and function in the MTM1 knockdown zebrafish model of XLMTM, demonstrating
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21133188 offsetBegin: 3665 offsetEnd: 3822 A: neurophysiology may still have MG. Treatment should be directed at ameliorating weakness with acetylcholinesterase blockers and modulating the immune system.
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22216416 offsetBegin: 427 offsetEnd: 558 A: is a consistent and early finding in AD. The treatment approach of inhibiting peripheral AchE for myasthenia gravis had effectively
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24220173 offsetBegin: 194 offsetEnd: 387 A: and pyridinium-isoquinolinium compounds were prepared as molecules potentially applicable in myasthenia gravis treatment. Their inhibitory ability towards human recombinant acetylcholinesterase
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21222577 offsetBegin: 165 offsetEnd: 318 A: promising therapeutic agents for the treatment of several neurological disorders such as Alzheimer's disease (AD), senile dementia, ataxia and myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24019417 offsetBegin: 0 offsetEnd: 162 A: OBJECTIVE: To evaluate the incidence, clinical features, diagnostic, and treatment trends of pediatric myasthenia in Canada. METHODS: Through established Canadian
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21975507 offsetBegin: 3660 offsetEnd: 3809 A: beneficial and sustained response to acetylcholinesterase inhibitor treatment. Most of the patients who had a muscle biopsy showed tubular aggregates
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/23235620 offsetBegin: 5109 offsetEnd: 5246 A: compared to placebo, no treatment or some other treatment; and (c) results reported separately for patients with ocular myasthenia (grade
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22849994 offsetBegin: 119 offsetEnd: 230 A: myasthenia gravis (MG) who developed optic neuritis after the treatment of MG for 22 years. At 10 years of age,
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/22849994 offsetBegin: 3485 offsetEnd: 3626 A: disappeared completely after the treatment with steroid pulse and plasma exchange. This case had 23 years of immunosuppressive treatment free
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 764 offsetEnd: 941 A: important differences regarding presentation and therapeutic options. We review the pathophysiology, clinical presentation, and treatment options for juvenile myasthenia gravis.
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 941 offsetEnd: 1105 A: options. We review the pathophysiology, clinical presentation, and treatment options for juvenile myasthenia gravis. RECENT FINDINGS: Randomized clinical studies of
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 1260 offsetEnd: 1410 A: myasthenia gravis. RECENT FINDINGS: Randomized clinical studies of myasthenia gravis have been carried out primarily in adult populations. As juvenile
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 1676 offsetEnd: 1817 A: As juvenile myasthenia gravis is rare, it has been difficult to collect prospective randomized controlled data to evaluate treatment outcomes
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/24141560 offsetBegin: 2114 offsetEnd: 2257 A: treatment outcomes and efficacy. A recent retrospective series suggests that, as in adult myasthenia gravis, thymectomy is a viable therapeutic
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/23234677 offsetBegin: 764 offsetEnd: 950 A: have antibodies against muscle-specific kinase. Information on the clinical course, treatment alternatives, and prognosis of pediatric muscle-specific kinase antibody-positive myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21614992 offsetBegin: 1216 offsetEnd: 1360 A: serum acetylcholine receptor antibodies. Acetylcholine esterase inhibitor drugs are used in treatment of CMS. A seven-month old male patient was
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 352 offsetEnd: 532 A: junction abolishes the naturally occurring 'safety factor' of synaptic transmission. Acetylcholinesterase inhibitors provide temporary symptomatic treatment of muscle weakness, but
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 532 offsetEnd: 704 A: factor' of synaptic transmission. Acetylcholinesterase inhibitors provide temporary symptomatic treatment of muscle weakness, but there is controversy about their long-term
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 1009 offsetEnd: 1158 A: their long-term efficacy, dosage and side effects. OBJECTIVES: To evaluate the efficacy of acetylcholinesterase inhibitors in all forms of myasthenia
Q:Which acetylcholinesterase inhibitors are used for treatment of myasthenia gravis? Document:http://www.ncbi.nlm.nih.gov/pubmed/21328290 offsetBegin: 1306 offsetEnd: 1466 A: of acetylcholinesterase inhibitors in all forms of myasthenia gravis. SEARCH STRATEGY: We searched The Cochrane Neuromuscular Disease Group Specialized Register
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 3959 offsetEnd: 4088 A: and proportions of the isochore classes. The relative density of genes, Alu and long interspersed nuclear element repeats and the
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 1260 offsetEnd: 1403 A: (particularly Alu elements) present in these upstream regions. This effect is completely separable from effects of isochore composition on gene
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/8276253 offsetBegin: 763 offsetEnd: 894 A: of Alu element retropositions within a TAA minisatellite. Extensive homologies between the left viral end and the host cellular DNA
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/11591470 offsetBegin: 3878 offsetEnd: 4016 A: more frequent in GC-poor isochores. Finally, the present results on Alu and LINE stability/exclusion predict significant losses of Alu DNA
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/8276253 offsetBegin: 505 offsetEnd: 627 A: in a genomic region which has been the target of multiple events of Alu element retropositions within a TAA minisatellite.
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/8276253 offsetBegin: 627 offsetEnd: 763 A: been the target of multiple events of Alu element retropositions within a TAA minisatellite. Extensive homologies between the left viral
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/11591470 offsetBegin: 4016 offsetEnd: 4154 A: the present results on Alu and LINE stability/exclusion predict significant losses of Alu DNA from the GC-poor isochores during evolution,
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 2535 offsetEnd: 2678 A: significant; (3) isochore boundaries are accurately defined to single base pair resolution; and (4) both gradual and abrupt isochore boundaries
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 3828 offsetEnd: 3959 A: features, mainly size distribution, G+C range, and proportions of the isochore classes. The relative density of genes, Alu and long
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 4088 offsetEnd: 4227 A: The relative density of genes, Alu and long interspersed nuclear element repeats and the different types of single nucleotide polymorphisms
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/22057813 offsetBegin: 236 offsetEnd: 353 A: elements, the Alu sequences, has been investigated for the past 30 years, and the vast majority of Alu sequences were
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 3694 offsetEnd: 3828 A: show many of the typical isochore features, mainly size distribution, G+C range, and proportions of the isochore classes. The relative
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 1541 offsetEnd: 1675 A: regions (LHGRs), thereby revealing the isochore structure of the human genome. The advantages of the isochore maps presented here are:
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 3545 offsetEnd: 3694 A: isochores revealed through DNA centrifugation. LHGRs show many of the typical isochore features, mainly size distribution, G+C range, and proportions
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 4516 offsetEnd: 4667 A: nucleotide polymorphisms on LHGRs also coincide with expectations in true isochores. Potential applications of isochore maps range from the improvement
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/22057813 offsetBegin: 702 offsetEnd: 839 A: highest density in GC-rich isochores. Ten years ago, it was discovered, however, that the small "youngest" (most recently transposed) Alu
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 1101 offsetEnd: 1260 A: compositional structure of repetitive genomic sequences (particularly Alu elements) present in these upstream regions. This effect is completely separable from
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 1403 offsetEnd: 1555 A: upstream regions. This effect is completely separable from effects of isochore composition on gene expression. The results implicate repetitive elements
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 1555 offsetEnd: 1708 A: separable from effects of isochore composition on gene expression. The results implicate repetitive elements with some functional role in transcriptional
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 2120 offsetEnd: 2257 A: genes in whose promoter regions they reside and lend credence to suggestions that the general phenomenon of repetitive element insertions
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 2257 offsetEnd: 2401 A: reside and lend credence to suggestions that the general phenomenon of repetitive element insertions may be a fundamental evolutionary mechanism
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/17141428 offsetBegin: 997 offsetEnd: 1147 A: sequence context. We show that Alu elements are more highly concentrated around housekeeping genes while various longer (>400-bp) repetitive sequences
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/17141428 offsetBegin: 1493 offsetEnd: 1654 A: repetitive sequences ("repeats"), including Long Interspersed Nuclear Element-1 (LINE-1) elements, are excluded from these regions. We further show that isochore
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/17141428 offsetBegin: 1654 offsetEnd: 1804 A: Nuclear Element-1 (LINE-1) elements, are excluded from these regions. We further show that isochore membership does not distinguish housekeeping genes
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/11591470 offsetBegin: 3737 offsetEnd: 3878 A: to LINEs, processed pseudogenes are also more frequent in GC-poor isochores. Finally, the present results on Alu and LINE stability/exclusion
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/11591470 offsetBegin: 4154 offsetEnd: 4301 A: LINE stability/exclusion predict significant losses of Alu DNA from the GC-poor isochores during evolution, a phenomenon apparently due to negative
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/9931467 offsetBegin: 2534 offsetEnd: 2659 A: gene frequency. (iv) The frequency of Alu sequences also increases with increasing GC, but attains a maximum in H2 isochores,
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/18032720 offsetBegin: 4315 offsetEnd: 4472 A: gene conversion. Fifth, transcription status and location in a particular isochore do not influence microsatellite mutability. Sixth, compared with intrinsic
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/18032720 offsetBegin: 4472 offsetEnd: 4625 A: location in a particular isochore do not influence microsatellite mutability. Sixth, compared with intrinsic features, regional genomic factors have only
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/15871047 offsetBegin: 4996 offsetEnd: 5139 A: evolutionary divergence shown by recently inserted Alu subfamilies and the higher frequency of old stand-alone Alus in L isochores-support such
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 1810 offsetEnd: 1938 A: advantages of the isochore maps presented here are: (1) sequence heterogeneities at different scales are shown in the same plot;
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 2229 offsetEnd: 2389 A: same plot; (2) pair-wise compositional differences between adjacent regions are all statistically significant; (3) isochore boundaries are accurately defined to
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 2389 offsetEnd: 2535 A: between adjacent regions are all statistically significant; (3) isochore boundaries are accurately defined to single base pair resolution; and (4)
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 2678 offsetEnd: 2818 A: defined to single base pair resolution; and (4) both gradual and abrupt isochore boundaries are simultaneously revealed. Taking advantage of
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 3398 offsetEnd: 3545 A: correspondence between LHGRs and true human isochores revealed through DNA centrifugation. LHGRs show many of the typical isochore features, mainly
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12468093 offsetBegin: 4227 offsetEnd: 4372 A: and long interspersed nuclear element repeats and the different types of single nucleotide polymorphisms on LHGRs also coincide with expectations
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/23430906 offsetBegin: 2150 offsetEnd: 2273 A: 18 and 19. Further analysis revealed that both the 5' and 3' breakpoints were located within highly homologous Alu elements
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/23430906 offsetBegin: 2273 offsetEnd: 2393 A: that both the 5' and 3' breakpoints were located within highly homologous Alu elements (Alu-Sz in intron 18 and Alu-Sq2,
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/23430906 offsetBegin: 4558 offsetEnd: 4688 A: 62 bp fragment corresponds to the Alu-Sz element integrated in intron 18.This represents the first description of a large deletion
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/22057813 offsetBegin: 466 offsetEnd: 580 A: and the vast majority of Alu sequences were shown to have the highest density in GC-rich isochores. Ten years ago,
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/22057813 offsetBegin: 2127 offsetEnd: 2251 A: sequences, and 2) assessing the densities of acceptor sites TTTT/AA in isochore families. We could conclude 1) that the open
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/22057813 offsetBegin: 2251 offsetEnd: 2370 A: of acceptor sites TTTT/AA in isochore families. We could conclude 1) that the open state of chromatin structure plays a
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/22057813 offsetBegin: 3070 offsetEnd: 3184 A: that the distribution of old Alus can be explained as due to Alu sequences being unstable in the GC-poor isochores
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/16551647 offsetBegin: 2548 offsetEnd: 2693 A: chicken, turkey, and quail. Analysis of individual substitution frequencies is consistent with the biased gene conversion (BGC) model of isochore
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/16551647 offsetBegin: 2693 offsetEnd: 2831 A: individual substitution frequencies is consistent with the biased gene conversion (BGC) model of isochore evolution, and it is likely that
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/12948482 offsetBegin: 943 offsetEnd: 1101 A: depends most strongly originates in the compositional structure of repetitive genomic sequences (particularly Alu elements) present in these upstream regions.
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/17141428 offsetBegin: 710 offsetEnd: 852 A: whether housekeeping genes can be distinguished from tissue-specific genes by their repetitive sequence context. We show that Alu elements are
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/17141428 offsetBegin: 852 offsetEnd: 997 A: from tissue-specific genes by their repetitive sequence context. We show that Alu elements are more highly concentrated around housekeeping genes
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/11591470 offsetBegin: 1369 offsetEnd: 1507 A: show such a different distribution in the genome. This problem was investigated here by studying the isochore distributions of subfamilies
Q:In which isochores are Alu elements enriched? Document:http://www.ncbi.nlm.nih.gov/pubmed/11591470 offsetBegin: 4301 offsetEnd: 4438 A: Alu DNA from the GC-poor isochores during evolution, a phenomenon apparently due to negative selection against sequences that differ from
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 1939 offsetEnd: 2080 A: cancer growth. TPL2 activation by over-expressing either wild-type or a constitutively activated form of TPL2 induced ADI growth, whereas the
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 2210 offsetEnd: 2332 A: form of TPL2 induced ADI growth, whereas the suppression of TPL2 expression and its kinase activity in ADI prostate cancer
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 3773 offsetEnd: 3920 A: prostate cancer progression. Furthermore, the suppression of TPL2 diminishes ADI prostate cancer growth and a high frequency of TPL2 overexpression
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 3920 offsetEnd: 4046 A: of TPL2 diminishes ADI prostate cancer growth and a high frequency of TPL2 overexpression in human ADI prostate cancer samples
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23613938 offsetBegin: 1788 offsetEnd: 1918 A: luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 1786 offsetEnd: 1939 A: serine/threonine kinase, as driving ADI prostate cancer growth. TPL2 activation by over-expressing either wild-type or a constitutively activated form of
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 0 offsetEnd: 113 A: Skin cancer is the most common form of cancer in the USA, with an estimated two million cases diagnosed annually.
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21282109 offsetBegin: 2541 offsetEnd: 2672 A: Mcm2-7 associate with Cdc45 and GINS to form a relatively stable CMG (Cdc45-MCM-GINS) complex. The CMG proteins also associate less
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23613938 offsetBegin: 1918 offsetEnd: 2054 A: form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/12090470 offsetBegin: 0 offsetEnd: 129 A: Inflammatory breast cancer (IBC) is the most lethal form of locally advanced breast cancer known. IBC carries a guarded prognosis
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/12565821 offsetBegin: 1488 offsetEnd: 1605 A: exploited as a strategy for killing human cancer cells, we used gene transfer experiments with a range of cancer cell
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/12565821 offsetBegin: 1605 offsetEnd: 1729 A: human cancer cells, we used gene transfer experiments with a range of cancer cell lines. We expressed the catalytic fragment
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 2080 offsetEnd: 2210 A: either wild-type or a constitutively activated form of TPL2 induced ADI growth, whereas the suppression of TPL2 expression and its
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 4046 offsetEnd: 4164 A: growth and a high frequency of TPL2 overexpression in human ADI prostate cancer samples validates TPL2 as a target for
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 1636 offsetEnd: 1765 A: this study, we used gene expression profiling to compare expression levels between Tpl2 (+/+) and Tpl2 (-) (/-) keratinocytes. We
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 3509 offsetEnd: 3637 A: that TPL2 kinase plays a critical role in the promotion of ADI prostate cancer progression. Furthermore, the suppression of TPL2
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 3637 offsetEnd: 3773 A: role in the promotion of ADI prostate cancer progression. Furthermore, the suppression of TPL2 diminishes ADI prostate cancer growth and
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 5048 offsetEnd: 5233 A: in 12-O-tetradecanoylphorbol-13-acetate-treated skin from Tpl2 (-/-) mice and grafted tumors formed from v-ras(Ha) retrovirus-infected Tpl2 (-/-) keratinocytes. Additionally, Tpl2 (-/-)
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 113 offsetEnd: 234 A: form of cancer in the USA, with an estimated two million cases diagnosed annually. Tumor progression locus 2 (Tpl2), also
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21282109 offsetBegin: 2287 offsetEnd: 2411 A: bidirectional replication forks in S phase. We also show that after initiation, Mcm2-7 associate with Cdc45 and GINS to form
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21282109 offsetBegin: 2411 offsetEnd: 2541 A: We also show that after initiation, Mcm2-7 associate with Cdc45 and GINS to form a relatively stable CMG (Cdc45-MCM-GINS) complex.
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/18367714 offsetBegin: 0 offsetEnd: 151 A: MicroRNAs (miRNAs) are small noncoding RNA molecules of 20-24 nucleotides that regulate gene expression. In animals, miRNAs form imperfect interactions
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/12694536 offsetBegin: 0 offsetEnd: 173 A: BACKGROUND: Nectins are Ca2+-independent immunoglobulin-like cell-cell adhesion molecules which associate with cadherins to form adherens junctions (AJs) in epithelial cells
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/22416126 offsetBegin: 1513 offsetEnd: 1668 A: Additionally, mammalian DBHS proteins associate with the architectural long noncoding RNA NEAT1 (Menε/β) to form paraspeckles, subnuclear bodies that alter
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21859479 offsetBegin: 3485 offsetEnd: 3638 A: tissue plasminogen activator (tPA) and matrix metallopeptidases (MMPs) is reported to associate with the development of cancer cell mobility, metastasis,
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21859479 offsetBegin: 3638 offsetEnd: 3798 A: metallopeptidases (MMPs) is reported to associate with the development of cancer cell mobility, metastasis, and subsequent malignant tumor. After administration
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/17682292 offsetBegin: 5211 offsetEnd: 5347 A: form colonies in soft agar, while FHL2 overexpression enhances colony formation of breast cancer cells. Thus, our findings indicate that
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21635933 offsetBegin: 1815 offsetEnd: 1951 A: these topologies can play a role in telomere regulation and gene expression. The core structures of G-quadruplexes form stable scaffolds
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/22724069 offsetBegin: 2968 offsetEnd: 3112 A: to form polymers and associate with membranes. Phosphorylation at these sites appears essential for CHMP4C function because their mutation leads
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/16238095 offsetBegin: 1584 offsetEnd: 1728 A: phosphorylated by c-Jun N-terminal kinase (JNK-1) associates with c-Fos to form the AP-1 transcription factor that activates gene expression. We
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23741254 offsetBegin: 142 offsetEnd: 275 A: 1 (NOR1) gene may be involved in the chemical carcinogenesis of hepatic cancer and nasopharyngeal carcinoma (NPC). We have previously
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23511334 offsetBegin: 2876 offsetEnd: 3025 A: into cells inducing gene silencing. Our explicit solvent molecular dynamics (MD) simulations showed that bolaamphiphiles associate with siRNAs due to
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/12565821 offsetBegin: 1369 offsetEnd: 1488 A: and explore whether it can be exploited as a strategy for killing human cancer cells, we used gene transfer experiments
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 1635 offsetEnd: 1786 A: we have identified TPL2, encoding a serine/threonine kinase, as driving ADI prostate cancer growth. TPL2 activation by over-expressing either wild-type
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 2332 offsetEnd: 2480 A: whereas the suppression of TPL2 expression and its kinase activity in ADI prostate cancer cells inhibited cell proliferation under androgen-depleted
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 2480 offsetEnd: 2635 A: and its kinase activity in ADI prostate cancer cells inhibited cell proliferation under androgen-depleted conditions. Most importantly, TPL2 is upregulated
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 3221 offsetEnd: 3366 A: model and the clinical prostate cancer specimens. CONCLUSIONS/SIGNIFICANCE: Together these data suggest that TPL2 kinase plays a critical role in
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/21267413 offsetBegin: 3366 offsetEnd: 3509 A: specimens. CONCLUSIONS/SIGNIFICANCE: Together these data suggest that TPL2 kinase plays a critical role in the promotion of ADI prostate cancer
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23892038 offsetBegin: 3409 offsetEnd: 3561 A: form in one optical plane and mesenchymal progenitor cells (10T1/2) differentiate into pericyte-like cells, which associate with the endothelial vessels
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/22303479 offsetBegin: 1497 offsetEnd: 1647 A: represses the tumor suppressor P53 in human cancer cells. Immunoprecipitation analysis shows that Piwil2 can directly associate with Signal Transducer
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/22303479 offsetBegin: 1647 offsetEnd: 1800 A: human cancer cells. Immunoprecipitation analysis shows that Piwil2 can directly associate with Signal Transducer and Activator of Transcription 3 (STAT3)
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23840421 offsetBegin: 1875 offsetEnd: 1995 A: (DRMs) along the secretory pathway. Its mature form is mainly insoluble in Lubrol WX, but does not associate with Triton
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23840421 offsetBegin: 1995 offsetEnd: 2118 A: mature form is mainly insoluble in Lubrol WX, but does not associate with Triton X-100-DRMs. To understand the mechanism of
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23386605 offsetBegin: 2893 offsetEnd: 3028 A: active form of STAT3, whereas tumor-derived mutants L71P, L91P and A95T significantly lost their ability to associate with STAT3, block
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23386605 offsetBegin: 3028 offsetEnd: 3173 A: mutants L71P, L91P and A95T significantly lost their ability to associate with STAT3, block gene expression, and suppress cellular transformation
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/23386605 offsetBegin: 3173 offsetEnd: 3316 A: lost their ability to associate with STAT3, block gene expression, and suppress cellular transformation and tumor growth in vivo. Additionally,
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 1492 offsetEnd: 1636 A: inflammation and increased skin carcinogenesis. In this study, we used gene expression profiling to compare expression levels between Tpl2 (+/+)
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 1765 offsetEnd: 1894 A: profiling to compare expression levels between Tpl2 (+/+) and Tpl2 (-) (/-) keratinocytes. We identified over 2000 genes as being
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 1894 offsetEnd: 2042 A: Tpl2 (+/+) and Tpl2 (-) (/-) keratinocytes. We identified over 2000 genes as being differentially expressed between genotypes. Functional annotation
Q:Which forms of cancer is the Tpl2 gene associated with? Document:http://www.ncbi.nlm.nih.gov/pubmed/24067898 offsetBegin: 5595 offsetEnd: 5751 A: Tpl2 (-/-) keratinocytes had significantly higher invasion, malignant conversion rates and increased endothelial cell tube formation when compared with Tpl2
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 3811 offsetEnd: 3938 A: its itaconic acid production on glucose. Nitrogen limitation was shown to be a crucial condition for the production of itaconic
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 3938 offsetEnd: 4069 A: Nitrogen limitation was shown to be a crucial condition for the production of itaconic acid. For itaconic acid concentrations above
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23727192 offsetBegin: 1504 offsetEnd: 1663 A: itaconic acid. Additional expression of aconitase, the second enzyme metabolically linking citric acid and itaconic acid improves productivity. However, proper
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 4069 offsetEnd: 4205 A: a crucial condition for the production of itaconic acid. For itaconic acid concentrations above 25 g/L, a significant product inhibition
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22009657 offsetBegin: 159 offsetEnd: 318 A: such as arachidonic acid (ARA, 20:4n-6), eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid (DPA, 22:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) are
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23889751 offsetBegin: 4204 offsetEnd: 4331 A: yeast-like growth makes U. maydis MB215 a promising candidate for the production of valuable chemicals such as itaconic acid or
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22956279 offsetBegin: 1545 offsetEnd: 1678 A: a P source. Glycerol was an excellent substrate for growth (10.2 g biomass L(-1)) and itaconic acid production (26.9 g L(-1)) by free
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22956279 offsetBegin: 1678 offsetEnd: 1838 A: excellent substrate for growth (10.2 g biomass L(-1)) and itaconic acid production (26.9 g L(-1)) by free fungal cells after 120-h fermentation. Simultaneously,
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22956279 offsetBegin: 1838 offsetEnd: 1998 A: L(-1)) and itaconic acid production (26.9 g L(-1)) by free fungal cells after 120-h fermentation. Simultaneously, A. terreus solubilized the insoluble phosphate
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 138 offsetEnd: 280 A: based transcriptome analysis towards the identification of genes related to itaconic acid production in Aspergillus terreus was carried out as
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22801376 offsetBegin: 2077 offsetEnd: 2199 A: palmitic acid (16:0), 18.5 wt.% oleic acid (18:1), 4.5 wt.% stearic acid (18:0) and 4.0 wt.% linolenic-ω3 acid (18:3). The
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 2566 offsetEnd: 2725 A: exemplary pretreatment methods on the cultivation and itaconic acid production of this fungus. Cellulose enzymatically hydrolysed in seawater and salt-assisted
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 3538 offsetEnd: 3680 A: as substrate. RESULTS: U. maydis was characterized on shake flask level regarding its itaconic acid production on glucose. Nitrogen limitation
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 3680 offsetEnd: 3811 A: characterized on shake flask level regarding its itaconic acid production on glucose. Nitrogen limitation was shown to be a crucial
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 4205 offsetEnd: 4354 A: of itaconic acid. For itaconic acid concentrations above 25 g/L, a significant product inhibition was observed. Performing experiments that simulated
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23889751 offsetBegin: 4331 offsetEnd: 4475 A: a promising candidate for the production of valuable chemicals such as itaconic acid or glycolipids from lignocellulosic biomass. Therefore, the
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/21853139 offsetBegin: 4369 offsetEnd: 4502 A: production capability. Toxigenic strains were also able to produce the toxins on media suggested for citric acid production with most
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/12359241 offsetBegin: 1773 offsetEnd: 1927 A: subvermispora intensively inhibited .OH production by the Fenton reaction by direct interaction with Fe ions, while non-substituted itaconic acid promoted
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/11791342 offsetBegin: 989 offsetEnd: 1096 A: 3 to 5, while some species even tolerate pH values as low as 1.5. Organic acid production can be stimulated
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 2605 offsetEnd: 2718 A: the citric acid producing fungus A. niger showed that it is possible to produce itaconic acid also in a different
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/15289678 offsetBegin: 2546 offsetEnd: 2681 A: Itaconic acid was successfully used as a buffer to overcome pH-induced limitations of cell growth and to facilitate enhanced production
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 0 offsetEnd: 138 A: BACKGROUND: In this paper, a clone based transcriptome analysis towards the identification of genes related to itaconic acid production in
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 280 offsetEnd: 405 A: of genes related to itaconic acid production in Aspergillus terreus was carried out as an extension of a previously published
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 1613 offsetEnd: 1786 A: for A. terreus. RESULTS: Besides the itaconic acid gene cluster (cis-aconitate decarboxylase, mitochondrial tri-carboxylic acid transporter and major facilitator superfamily
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 1786 offsetEnd: 1978 A: itaconic acid gene cluster (cis-aconitate decarboxylase, mitochondrial tri-carboxylic acid transporter and major facilitator superfamily transporter) discovered previously, additional genes of
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 4544 offsetEnd: 4685 A: based transcription array to identify genes correlating with itaconic acid production revealed novel genes both in the central metabolism and
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 4685 offsetEnd: 4820 A: correlating with itaconic acid production revealed novel genes both in the central metabolism and in other more secondary pathways such
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 2427 offsetEnd: 2566 A: to evaluate the influence of three exemplary pretreatment methods on the cultivation and itaconic acid production of this fungus. Cellulose
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 2725 offsetEnd: 2888 A: and itaconic acid production of this fungus. Cellulose enzymatically hydrolysed in seawater and salt-assisted organic-acid catalysed cellulose were investigated as
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 5016 offsetEnd: 5129 A: 3.5 osmol/L as well as of 0.1 M oxalic acid. The production of itaconic acid was achieved on pretreated cellulose
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 5129 offsetEnd: 5250 A: 0.1 M oxalic acid. The production of itaconic acid was achieved on pretreated cellulose in seawater and on the hydrolysed
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23727192 offsetBegin: 0 offsetEnd: 119 A: Itaconic acid is an unsaturated dicarboxylic acid which has a high potential as a biochemical building block. It can be
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23727192 offsetBegin: 1663 offsetEnd: 1814 A: the second enzyme metabolically linking citric acid and itaconic acid improves productivity. However, proper organelle targeting of the enzymes appears
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23727192 offsetBegin: 1814 offsetEnd: 1946 A: acid and itaconic acid improves productivity. However, proper organelle targeting of the enzymes appears to be an important point to
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23420787 offsetBegin: 0 offsetEnd: 122 A: Itaconic acid is an unsaturated dicarbonic acid which has a high potential as a biochemical building block, because it can
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24027910 offsetBegin: 5247 offsetEnd: 5400 A: every 20 days. The biotechnological potential for the production of bioactive compounds in these species for pharmacological, agricultural and industrial
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24304666 offsetBegin: 4395 offsetEnd: 4544 A: based transcriptome analysis using a clone based transcription array to identify genes correlating with itaconic acid production revealed novel genes
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22801376 offsetBegin: 1954 offsetEnd: 2077 A: wt.% linoleic-ω6 acid (18:2), 20.4 wt.% palmitic acid (16:0), 18.5 wt.% oleic acid (18:1), 4.5 wt.% stearic acid (18:0) and
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/23298766 offsetBegin: 442 offsetEnd: 594 A: compounds such as methacrylic acid in industry, the economic efficiency of the current biotechnological production processes with the fungus Aspergillus
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/12359241 offsetBegin: 1463 offsetEnd: 1622 A: alkylitaconic acid (ceriporic acid B) produced by the selective white-rot fungus Ceriporiopsis subvermispora intensively inhibited .OH production by the Fenton
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/11791342 offsetBegin: 1824 offsetEnd: 1953 A: is exploited in large-scale production of a number of organic acids like citric-, gluconic- and itaconic acid. Both in production
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22009657 offsetBegin: 0 offsetEnd: 159 A: Very long chain polyunsaturated fatty acids such as arachidonic acid (ARA, 20:4n-6), eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid (DPA, 22:5n-3)
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24068337 offsetBegin: 956 offsetEnd: 1113 A: (e.g., high secretion capacity and efficient production of metabolic products) of these species have increased the biotechnological applications of bacteria.
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/24068337 offsetBegin: 1113 offsetEnd: 1267 A: production of metabolic products) of these species have increased the biotechnological applications of bacteria. However, owing to multiplicity from genes
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/21052988 offsetBegin: 2771 offsetEnd: 2909 A: production of high-value organic acids like succinic acid, lactic acid, 3-hydroxypropanoic acid and glucaric acid as well as alcohols like
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22009657 offsetBegin: 318 offsetEnd: 480 A: eicosapentaenoic acid (EPA, 20:5n-3), docosapentaenoic acid (DPA, 22:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) are essential components of cell membranes, and
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/12359241 offsetBegin: 2067 offsetEnd: 2207 A: with Fe ions, while non-substituted itaconic acid promoted the Fenton reaction. Suppression of the Fenton reaction by the alkylitaconic acid
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22801376 offsetBegin: 1835 offsetEnd: 1954 A: peaks for the seed oil: 42.9 wt.% linoleic-ω6 acid (18:2), 20.4 wt.% palmitic acid (16:0), 18.5 wt.% oleic acid (18:1),
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22801376 offsetBegin: 2199 offsetEnd: 2317 A: acid (18:1), 4.5 wt.% stearic acid (18:0) and 4.0 wt.% linolenic-ω3 acid (18:3). The sum of the saturated palmitic and
Q:Which species may be used for the biotechnological production of itaconic acid? Document:http://www.ncbi.nlm.nih.gov/pubmed/22480369 offsetBegin: 7167 offsetEnd: 7313 A: affect the subsequent itaconic acid production. Although U. maydis is insusceptible to most possible impurities from pretreatment, high amounts of
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 2221 offsetEnd: 2374 A: histone methyltransferase to the imprinting control regions, inhibiting production of an activating methylation mark on histone H3 lysine 4. H1-dependent
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/24097338 offsetBegin: 263 offsetEnd: 401 A: the polycomb group complex, is vital for stem cell development, including hematopoiesis. Its primary function, to deposit the histone mark
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/24097338 offsetBegin: 401 offsetEnd: 562 A: for stem cell development, including hematopoiesis. Its primary function, to deposit the histone mark H3K27me3, promotes transcriptional repression. The activity
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/24097338 offsetBegin: 562 offsetEnd: 712 A: Its primary function, to deposit the histone mark H3K27me3, promotes transcriptional repression. The activity of EZH2 influences cell fate regulation,
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20599797 offsetBegin: 3589 offsetEnd: 3740 A: In vascular endothelial cells the histone methyltransferase Set7 can write the mono-methylation mark H3K4m1 and this methyl-writing enzyme is recruited
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23852375 offsetBegin: 3149 offsetEnd: 3270 A: the deposit of H3K27me3 mark at the Bim promoter. SUZ12 and the histone methyltransferase EZH2, two PRC2 subunits bind to
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20599797 offsetBegin: 3452 offsetEnd: 3589 A: H3K4m3, on the NFκB p65 gene. In vascular endothelial cells the histone methyltransferase Set7 can write the mono-methylation mark H3K4m1
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23852375 offsetBegin: 3020 offsetEnd: 3149 A: of Polycomb is directly responsible for the deposit of H3K27me3 mark at the Bim promoter. SUZ12 and the histone methyltransferase
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 2773 offsetEnd: 2922 A: effect on modifications deposited during transcription initiation. We also found that the histone H3S10 phosphorylation mark is catalyzed by mitogen-
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 2922 offsetEnd: 3061 A: initiation. We also found that the histone H3S10 phosphorylation mark is catalyzed by mitogen- and stress-activated protein kinase 1 (MSK1)
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20599797 offsetBegin: 3740 offsetEnd: 3884 A: methyltransferase Set7 can write the mono-methylation mark H3K4m1 and this methyl-writing enzyme is recruited as a gene co-activator in response
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20599797 offsetBegin: 3884 offsetEnd: 4023 A: mark H3K4m1 and this methyl-writing enzyme is recruited as a gene co-activator in response to glucose. Furthermore, Set7 knockdown prevents
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 267 offsetEnd: 380 A: histones. Here we show that the H1 linker histone plays a key role in regulating both DNA methylation and histone
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23024815 offsetBegin: 0 offsetEnd: 148 A: Drosophila PR-Set7 or SET8 is a histone methyltransferase that specifically monomethylates histone H4 lysine 20 (H4K20). L(3)MBT has been identified
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23024815 offsetBegin: 148 offsetEnd: 297 A: histone methyltransferase that specifically monomethylates histone H4 lysine 20 (H4K20). L(3)MBT has been identified as a reader of methylated H4K20.
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23625014 offsetBegin: 1508 offsetEnd: 1672 A: are found in the SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain-containing lysine methyltransferases SET7 and SETDB1, whereby the histone H3 trimethylated on
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23625014 offsetBegin: 1672 offsetEnd: 1838 A: Enhancer-of-zeste, Trithorax) domain-containing lysine methyltransferases SET7 and SETDB1, whereby the histone H3 trimethylated on lysine 4 (H3K4 (me3) ) modification
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23625014 offsetBegin: 2318 offsetEnd: 2444 A: the histone H3 trimethylated on lysine 9 (H3K9 (me3) ) modification prevents methylation by SET7 on H3K4. A similar cross-talk
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/24097338 offsetBegin: 712 offsetEnd: 869 A: histone mark H3K27me3, promotes transcriptional repression. The activity of EZH2 influences cell fate regulation, namely the balance between self-renewal and
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20599797 offsetBegin: 3326 offsetEnd: 3452 A: with H3K4m1, but not H3K4m2 and H3K4m3, on the NFκB p65 gene. In vascular endothelial cells the histone methyltransferase Set7
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 2067 offsetEnd: 2221 A: interferes with binding of the SET7/9 histone methyltransferase to the imprinting control regions, inhibiting production of an activating methylation mark
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 2374 offsetEnd: 2511 A: regions, inhibiting production of an activating methylation mark on histone H3 lysine 4. H1-dependent recruitment of DNMT1 and DNMT3B and
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 2511 offsetEnd: 2640 A: methylation mark on histone H3 lysine 4. H1-dependent recruitment of DNMT1 and DNMT3B and interference with the binding of SET7/9
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 291 offsetEnd: 436 A: structural and functional diversity in biology. These modifications are encrypted as histone codes or histone languages and function to establish
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/19829087 offsetBegin: 393 offsetEnd: 540 A: of histone lysine methyltransferases. Histone lysine methylation is known to either activate or repress gene expression depending upon the position
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 380 offsetEnd: 491 A: H1 linker histone plays a key role in regulating both DNA methylation and histone H3 methylation at the H19 and
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23852375 offsetBegin: 2531 offsetEnd: 2651 A: and by promoting the trimethylation of histone 3 on lysine 27 (H3K27me3, a repressive histone mark) on the Bim promoter.
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 436 offsetEnd: 578 A: These modifications are encrypted as histone codes or histone languages and function to establish and maintain heritable epigenetic codes that
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 3061 offsetEnd: 3204 A: histone H3S10 phosphorylation mark is catalyzed by mitogen- and stress-activated protein kinase 1 (MSK1) and is recognized by a 14-3-3ζ/14-3-3ε
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23852375 offsetBegin: 2651 offsetEnd: 2772 A: histone 3 on lysine 27 (H3K27me3, a repressive histone mark) on the Bim promoter. The PRC2 repressive complex of Polycomb
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23852375 offsetBegin: 2772 offsetEnd: 2899 A: a repressive histone mark) on the Bim promoter. The PRC2 repressive complex of Polycomb is directly responsible for the deposit
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/19829087 offsetBegin: 258 offsetEnd: 393 A: to the discoveries of a variety of histone lysine methyltransferases. Histone lysine methylation is known to either activate or repress
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23852375 offsetBegin: 2899 offsetEnd: 3020 A: Bim promoter. The PRC2 repressive complex of Polycomb is directly responsible for the deposit of H3K27me3 mark at the Bim
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/19829087 offsetBegin: 121 offsetEnd: 258 A: of histones have moved rapidly thanks to the discoveries of a variety of histone lysine methyltransferases. Histone lysine methylation is
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 142 offsetEnd: 267 A: methylation and posttranslational modifications of core histones. Here we show that the H1 linker histone plays a key role in
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 155 offsetEnd: 291 A: a major contributing factor to the structural and functional diversity in biology. These modifications are encrypted as histone codes or
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 1584 offsetEnd: 1720 A: is not fully understood. Here we describe spatial and temporal analyses of the histone modifications that are introduced during estrogen
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 1720 offsetEnd: 1881 A: describe spatial and temporal analyses of the histone modifications that are introduced during estrogen receptor α (ERα)-activated transcription. We demonstrated
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 2039 offsetEnd: 2193 A: during estrogen receptor α (ERα)-activated transcription. We demonstrated that aborting RNA polymerase II caused a disruption of the histone modifications
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 4559 offsetEnd: 4733 A: monomethylation is implicated in both transcription initiation and elongation. Our experiments provide a relatively comprehensive analysis of histone modifications associated
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20404328 offsetBegin: 1960 offsetEnd: 2110 A: of our epigenetic studies. Transcriptional silencing in both glioma and breast carcinoma cells predominantly involved the repressive histone H3 Lys-27
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20404328 offsetBegin: 2259 offsetEnd: 2418 A: cells predominantly involved the repressive histone H3 Lys-27 trimethylation (H3K27me3) mark. In turn, epigenetic stimulation was primarily performed through a
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/20404328 offsetBegin: 4787 offsetEnd: 4952 A: confirmed using orthotopic xenografts and tumor specimens. We suggest that the epigenetic mechanisms allow gliomas to deposit an invasion-promoting collagen-enriched
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/19829087 offsetBegin: 1407 offsetEnd: 1552 A: those enzymes, the most extensively studied is Set9, a SET domain-containing lysine methyltransferase. Set9 was initially found to target histone
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/19684477 offsetBegin: 1613 offsetEnd: 1762 A: histone and non-histone proteins. Recent reports have suggested a new mechanism of epigenetic gene regulation via SET7/9 modulated DNMT1 methylation.
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/23302691 offsetBegin: 601 offsetEnd: 700 A: and histone H3 methylation at the H19 and Gtl2 loci in mouse ES cells. Some, but not all, murine H1
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 0 offsetEnd: 155 A: Transcription regulation by histone modifications is a major contributing factor to the structural and functional diversity in biology. These modifications
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 1881 offsetEnd: 2039 A: the histone modifications that are introduced during estrogen receptor α (ERα)-activated transcription. We demonstrated that aborting RNA polymerase II caused
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 2193 offsetEnd: 2339 A: We demonstrated that aborting RNA polymerase II caused a disruption of the histone modifications that are associated with transcription elongation
Q:Which histone marks are deposited by Set7? Document:http://www.ncbi.nlm.nih.gov/pubmed/21378170 offsetBegin: 2339 offsetEnd: 2468 A: II caused a disruption of the histone modifications that are associated with transcription elongation but had a minimal effect on
